Protagonist Therapeutics Inc banner

Protagonist Therapeutics Inc
XBER:PGF

Watchlist Manager
Protagonist Therapeutics Inc Logo
Protagonist Therapeutics Inc
XBER:PGF
Watchlist
Price: 75 EUR Market Closed
Market Cap: €2.9B

Intrinsic Value

The intrinsic value of one PGF stock under the Base Case scenario is 25.03 EUR. Compared to the current market price of 75 EUR, Protagonist Therapeutics Inc is Overvalued by 67%.

PGF Intrinsic Value
25.03 EUR
Overvaluation 67%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Protagonist Therapeutics Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about PGF?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is PGF valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Protagonist Therapeutics Inc.

Explain Valuation
Alternatives to PGF

Wall St
Price Targets

Dividends

Protagonist Therapeutics Inc
does not pay dividends
Shareholder Yield

Competitive Landscape

Ownership

PTGX Insider Trading
Buy and sell transactions by insiders

PGF News

What is the Intrinsic Value of one PGF stock?

The intrinsic value of one PGF stock under the Base Case scenario is 25.03 EUR.

Is PGF stock undervalued or overvalued?

Compared to the current market price of 75 EUR, Protagonist Therapeutics Inc is Overvalued by 67%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett